CC BY-NC-ND 4.0 · Journal of Diabetes and Endocrine Practice 2021; 04(04): 167-174
DOI: 10.4103/jdep.jdep_34_21
Original Article

Clinical practice patterns in the management of thyroid nodules: The first survey from the Middle East and Africa

Salem Beshyah
1   Department of Medicine, Dubai Medical College for Girls, Dubai
2   Yas Clinic Khalifa City, Abu Dhabi, UAE
,
Aly Khalil
3   Imperial College London Diabetes Center, Abu Dhabi, UAE
› Author Affiliations

Objective: We sought to scope the practices in managing thyroid nodules in the Middle East and Africa (MEA). Materials and Methods: Survey of a convenience sample of physicians concerned with the management of thyroid disease. Results: Two hundred and twelve responses are included. Fine needle aspiration (FNA) is performed chiefly using ultrasound guidance (74.9%), generally by radiologists (47.1%). Respondents have a lower threshold for FNA than recommended. Management depends on the FNA cytology, with the follicular lesion of undetermined significance/atypia of undetermined significance resulting in repeat FNA for cytology (40.7%), immediate referral for thyroid surgery (32.9%), or molecular testing (13.2%). Follicular neoplasms are referred for lobectomy or total thyroidectomy by 81.6% of respondents. Nodules suspicious for malignancy are referred for thyroid surgery by 76.6% and for molecular testing by 20.1%. Respondents are less likely to perform FNA in an octogenarian than a younger patient with a comparable nodule. For a multinodular goiter, 29.9%, 25.9%, or 17.8% of respondents would, respectively, sample the largest 2–3 nodules, single largest nodule, or all nodules >1 cm in size. During pregnancy, respondents would perform FNA with nodular growth (27.1%) in the absence of nodular growth (25.6%), but more respondents (35.2%) would defer FNA until after pregnancy. Conclusions: The physicians' survey revealed a practice pattern in managing thyroid nodules in the MEA region, including both agreements and deviations from current guidelines. Focused quality assurance exercises, education, and research are needed.

Financial support and sponsorship

Nil.




Publication History

Received: 23 July 2021

Accepted: 29 August 2021

Article published online:
14 July 2022

© 2021. Gulf Association of Endocrinology and Diabetes (GAED). All rights reserved. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Burman KD, Wartofsky L. Clinical practice. Thyroid nodules. N Engl J Med 2015;373:2347-56.
  • 2 Russ G, Leboulleux S, Leenhardt L, Hegedüs L. Thyroid incidentalomas: Epidemiology, risk stratification with ultrasound and workup. Eur Thyroid J 2014;3:154-63.
  • 3 Kang HW, No JH, Chung JH, Min YK, Lee MS, Lee MK, et al. Prevalence, clinical and ultrasonographic characteristics of thyroid incidentalomas. Thyroid 2004;14:29-33.
  • 4 Guth S, Theune U, Aberle J, Galach A, Bamberger CM. Very high prevalence of thyroid nodules detected by high frequency (13 MHz) ultrasound examination. Eur J Clin Invest 2009;39:699-706.
  • 5 American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009;19:1167-214.
  • 6 Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 2016;26:1-133.
  • 7 Bennedbaek FN, Hegedüs L. Management of the solitary thyroid nodule: Results of a North American survey. J Clin Endocrinol Metab 2000;85:2493-8.
  • 8 Bennedbaek FN, Perrild H, Hegedüs L. Diagnosis and treatment of the solitary thyroid nodule. Results of a European survey. Clin Endocrinol (Oxf) 1999;50:357-63.
  • 9 Burch HB, Burman KD, Cooper DS, Hennessey JV, Vietor NO. A 2015 survey of clinical practice patterns in the management of thyroid nodules. J Clin Endocrinol Metab 2016;101:2853-62.
  • 10 Beshyah SA, Sherif IH, Chentli F, Hamrahian A, Khalil AB, Raef H, et al. Management of prolactinomas: A survey of physicians from the Middle East and North Africa. Pituitary 2017;20:231-40.
  • 11 Beshyah SA, Khalil AB, Sherif IH, Benbarka MM, Raza SA, Hussein W, et al. A survey of clinical practice patterns in management of Graves disease in the Middle East and North Africa. Endocr Pract 2017;23:299-308.
  • 12 Beshyah SA, Sherif IH, Mustafa HE, Saadi HF. Patterns of clinical management of hypothyroidism in adults: An electronic survey of physicians from the Middle East and Africa. J Diabetes Endocr Pract 2021;4:75-82.
  • 13 Ahmad MM, Buhairy B, Al Mousawi F, Al-Shahrani F, Brema I, Al-Dahmani KM, et al. Physicians' perceptions and practices in management of acromegaly in the MENA Region. Hormones (Athens) 2018;17:373-81.
  • 14 Beshyah SA, Ali KF. Management of adrenal insufficiency: A survey of perceptions and practices of physicians from the Middle East and North Africa. Diabetes Endocr Pract. [Epub ahead of print]. Available from: https://www.jdeponline.com/preprintarticle.asp?id=324789. [Last accessed on 2021 Aug 29].
  • 15 Alawadhi R, Matalkah A, Alzaabi S, Ahmed N, Alduaij A, Sabri A, et al. Epidemiology and surgical characteristics of thyroid cancer in United Arab Emirates: Review of 100 consecutive patients. J Diabetes Endocr Pract 2020;3:79-83.
  • 16 Alawadhi R, Matalkah A, Ahmed N, Alduaij A, Sabri A, El-Kaissi S, et al. Accuracy of fine-needle aspiration cytology for detecting cancer in resected thyroid nodules at a referral hospital. J Diabetes Endocr Pract 2021;4:19-22.
  • 17 Al-Lawati NA, Shenoy SM, Al-Bahrani BJ, Al-Lawati JA. Increasing thyroid cancer incidence in Oman: A joinpoint trend analysis. Oman Med J 2020;35:e98.
  • 18 Baloch ZW, LiVolsi VA, Asa SL, Rosai J, Merino MJ, Randolph G, et al. Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: A synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol 2008;36:425-37.
  • 19 Ali SZ. Thyroid cytopathology: Bethesda and beyond. Acta Cytol 2011;55:4-12.
  • 20 Davenport C, Alderson J, Yu IG, Magner AC, M O'Brien D, Ghiollagain MN, et al. A review of the propriety of thyroid ultrasound referrals and their follow-up burden. Endocrine 2019;65:595-600.
  • 21 Ahn HS, Kim HJ, Welch HG. Korea's thyroid-cancer “epidemic”-screening and overdiagnosis. N Engl J Med 2014;371:1765-7.
  • 22 Gharib H, Papini E, Garber JR, Duick DS, Harrell RM, Hegedüs L, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules-2016 update. Endocr Pract 2016;22:622-39.
  • 23 Shrestha M, Crothers BA, Burch HB. The impact of thyroid nodule size on the risk of malignancy and accuracy of fine-needle aspiration: A 10-year study from a single institution. Thyroid 2012;22:1251-6.
  • 24 Oertel YC, Miyahara-Felipe L, Mendoza MG, Yu K. Value of repeated fine needle aspirations of the thyroid: An analysis of over ten thousand FNAs. Thyroid 2007;17:1061-6.
  • 25 Durante C, Costante G, Lucisano G, Bruno R, Meringolo D, Paciaroni A, et al. The natural history of benign thyroid nodules. JAMA 2015;313:926-35.
  • 26 Rosário PW, Calsolari MR. What is the best criterion for repetition of fine-needle aspiration in thyroid nodules with initially benign cytology? Thyroid 2015;25:1115-20.
  • 27 Kwak JY, Koo H, Youk JH, Kim MJ, Moon HJ, Son EJ, et al. Value of US correlation of a thyroid nodule with initially benign cytologic results. Radiology 2010;254:292-300.
  • 28 Kim SY, Han KH, Moon HJ, Kwak JY, Chung WY, Kim EK. Thyroid nodules with benign findings at cytologic examination: Results of long-term follow-up with US. Radiology 2014;271:272-81.
  • 29 Oczko-Wojciechowska M, Kotecka-Blicharz A, Krajewska J, Rusinek D, Barczyński M, Jarząb B, et al. European perspective on the use of molecular tests in the diagnosis and therapy of thyroid neoplasms. Gland Surg 2020;9:S69-76.
  • 30 Twining CL, Lupo MA, Tuttle RM. Implementing key changes in the American Thyroid Association 2015 thyroid nodules/differentiated thyroid cancer guidelines across practice types. Endocr Pract 2018;24:833-40.
  • 31 Alawadhi E, Al-Madouj A, Al-Zahrani A. Trends in thyroid cancer incidence in the Gulf Cooperation Council states: A 15-year analysis. Gulf J Oncolog 2020;1:31-8.
  • 32 Khalil AB, Altrabulsi B, Dina R. Thyroid nodules in the Gulf: Renewed interest and ongoing debate. J Diabetes Endocr Pract 2021;4:4-5.